Evidence map›Paper›PMID 30364284›Full record

ArticleFrontiers in immunology2018

IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During

Jimena Tosello Boari, Cintia L Araujo Furlan, Facundo Fiocca Vernengo, Constanza Rodriguez, María C Ramello, María C Amezcua Vesely, Melisa Gorosito Serrán, Nicolás G Nuñez, Wilfrid Richer, Eliane Piaggio and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. The Role of the CD28 Family Receptors in T-Cell Immunomodulation.International journal of molecular sciences · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Type 17 immunity promotes the exhaustion of CD8Journal for immunotherapy of cancer · 2021
    Article
  18. Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Jimena Tosello BoariDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Cintia L Araujo FurlanDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Facundo Fiocca VernengoDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Constanza RodriguezDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
María C RamelloDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
María C Amezcua VeselyDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Melisa Gorosito SerránDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Nicolás G NuñezSiRIC TransImm "Translational Immunotherapy Team," Translational Research Department, Research Center, PSL Research University, INSERM U932, Institut Curie, Paris, France.
Wilfrid RicherSiRIC TransImm "Translational Immunotherapy Team," Translational Research Department, Research Center, PSL Research University, INSERM U932, Institut Curie, Paris, France.
Eliane PiaggioSiRIC TransImm "Translational Immunotherapy Team," Translational Research Department, Research Center, PSL Research University, INSERM U932, Institut Curie, Paris, France.
Carolina L MontesDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Adriana GruppiDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Eva V Acosta RodríguezDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARResearch Centre in Biological Chemistry of Córdoba · ARUniversidad Nacional de Córdoba · ARInserm · FRInstitut Curie · FR

Funding

IL-17RA-signaling cytokines in the regulation of CD8 T cell immunity to T. cruziR01AI110340 · NIAID · NATIONAL RESEARCH COUNCIL OF ARGENTINA · PI ACOSTA RODRIGUEZ, EVA V · 2014 to 2018
$667k
NIAID NIH HHS R01 AI110340
6 · The paper itself

Abstract

The IL-17 family contributes to host defense against many intracellular pathogens by mechanisms that are not fully understood. CD8+ T lymphocytes are key elements against intracellular microbes, and their survival and ability to mount cytotoxic responses are orchestrated by several cytokines. Here, we demonstrated that IL-17RA-signaling cytokines sustain pathogen-specific CD8+ T cell immunity. The absence of IL-17RA and IL-17A/F during

Indexed as

Signal TransductionAdoptive TransferAnimalsApoptosisCD8-Positive T-LymphocytesCell SurvivalChagas DiseaseCytokinesFemaleHost-Pathogen InteractionsImmunomodulationInterleukin-17Lymphocyte ActivationLymphocyte CountMaleMiceCytokinesIl17ra protein, mouseInterleukin-17Receptors, Interleukin-17apoptosisCD8+ T cellscellularchagas diseaseeffector functionexhausted T cellsIL-17immunity

Identifiers

PMID30364284
PMCPMC6193063
OpenAlexW2953163965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.